Pacira BioSciences, Inc.
US ˙ NasdaqGS ˙ US6951271005

SecurityPCRX / Pacira BioSciences, Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership1,392,548 shares
Latest Disclosed Value $ 31,471,623
Morgan Stanley reports 16.77% increase in ownership of PCRX / Pacira BioSciences, Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 1,392,548 shares of Pacira BioSciences, Inc. (US:PCRX) valued at $31,471,585 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 1,192,594 shares of Pacira BioSciences, Inc.. This represents a change in shares of 16.77% during the quarter. The current value of the position is $31,680,467 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F PACIRA BIOSCIENCES COM 695127100 1,392,548 199,954 16.77 31,472 1.97 0.0019
2026-05-27 2025-12-31 13F/A-1 PACIRA BIOSCIENCES COM 695127100 1,192,594 49,832 4.36 30,864 4.81 0.0018
2026-02-13 2025-12-31 13F PACIRA BIOSCIENCES COM 695127100 1,192,594 49,832 30,864 0.0018
2026-05-27 2025-09-30 13F/A-1 PACIRA BIOSCIENCES COM 695127100 1,142,762 192,726 20.29 29,449 29.70 0.0018
2025-11-14 2025-09-30 13F PACIRA BIOSCIENCES COM 695127100 1,142,762 192,726 29,449 0.0018
2025-08-15 2025-06-30 13F PACIRA BIOSCIENCES COM 695127100 950,036 -47,570 -4.77 22,706 -8.41 0.0015
2025-05-15 2025-03-31 13F PACIRA BIOSCIENCES COM 695127100 997,606 -107,168 -9.70 24,791 19.11 0.0018
2025-05-15 2024-12-31 13F/A-1 PACIRA BIOSCIENCES COM 695127100 1,104,774 -491,115 -30.77 20,814 -13.34 0.0015
2025-02-14 2024-12-31 13F PACIRA BIOSCIENCES COM 695127100 1,104,774 -491,115 20,814 0.0015
2025-05-14 2024-09-30 13F/A-2 PACIRA BIOSCIENCES COM 695127100 1,595,889 1,079,724 209.18 24,018 62.65 0.0017
2025-02-14 2024-09-30 13F/A-1 PACIRA BIOSCIENCES COM 695127100 1,595,889 1,079,724 24,018 0.0017
2024-11-14 2024-09-30 13F PACIRA BIOSCIENCES COM 695127100 1,595,889 1,079,724 24,018 0.0002
2025-05-14 2024-06-30 13F/A-2 PACIRA BIOSCIENCES COM 695127100 516,165 -154,162 -23.00 14,767 -24.60 0.0011
2024-10-17 2024-06-30 13F/A-1 PACIRA BIOSCIENCES COM 695127100 516,165 -154,162 14,767 0.0011
2024-08-14 2024-06-30 13F PACIRA BIOSCIENCES COM 695127100 516,165 -154,162 14,767 0.0011
2024-10-17 2024-03-31 13F/A-2 PACIRA BIOSCIENCES COM 695127100 670,327 -15,007 -2.19 19,587 -15.30 0.0016
2024-08-16 2024-03-31 13F/A-1 PACIRA BIOSCIENCES COM 695127100 670,327 -15,007 19,587 0.0002
2024-05-15 2024-03-31 13F PACIRA BIOSCIENCES COM 695127100 670,327 -15,007 19,587 0.0016
2024-08-16 2023-12-31 13F/A-1 PACIRA BIOSCIENCES COM 695127100 685,334 224,011 48.56 23,123 63.38 0.0020
2024-02-13 2023-12-31 13F PACIRA BIOSCIENCES COM 695127100 685,334 224,011 23,123 0.0020
2023-11-15 2023-09-30 13F PACIRA BIOSCIENCES COM 695127100 461,323 -98,033 -17.53 14,153 -36.85 0.0014
2023-08-14 2023-06-30 13F PACIRA BIOSCIENCES COM 695127100 559,356 28,025 5.27 22,413 3.37 0.0022
2023-05-15 2023-03-31 13F PACIRA BIOSCIENCES COM 695127100 531,331 91,961 20.93 21,684 27.82 0.0023
2023-02-14 2022-12-31 13F PACIRA BIOSCIENCES COM 695127100 439,370 37,582 9.35 16,964 -20.62 0.0019
2022-11-14 2022-09-30 13F PACIRA BIOSCIENCES COM 695127100 401,788 -26,742 -6.24 21,371 -14.46 0.0029
2022-10-27 2022-06-30 13F/A-1 PACIRA BIOSCIENCES COM 695127100 428,530 146,456 51.92 24,984 16.06 0.0032
2022-08-15 2022-06-30 13F PACIRA BIOSCIENCES COM 695127100 428,530 146,456 24,984 0.0032
2022-10-27 2022-03-31 13F/A-1 PACIRA BIOSCIENCES COM 695127100 282,074 43,922 18.44 21,527 50.22 0.0029
2022-05-13 2022-03-31 13F PACIRA BIOSCIENCES COM 695127100 282,074 43,922 21,527 0.0029
2022-02-14 2021-12-31 13F PACIRA BIOSCIENCES COM 695127100 238,152 -13,533 -5.38 14,330 1.67 0.0018
2021-11-15 2021-09-30 13F PACIRA BIOSCIENCES COM 695127100 251,685 -171,819 -40.57 14,094 -45.16 0.0019
2021-08-23 2021-06-30 13F/A-1 PACIRA BIOSCIENCES COM 695127100 423,504 141,309 50.07 25,698 29.93 0.0034
2021-08-16 2021-06-30 13F PACIRA BIOSCIENCES COM 695127100 423,504 141,309 25,698 0.0007
2021-05-17 2021-03-31 13F PACIRA BIOSCIENCES COM 695127100 282,195 51,345 22.24 19,778 43.16 0.0029
2021-02-16 2020-12-31 13F PACIRA BIOSCIENCES COM 695127100 230,850 34,783 17.74 13,815 17.21 0.0021
2020-11-13 2020-09-30 13F PACIRA BIOSCIENCES COM 695127100 196,067 66,640 51.49 11,787 73.57 0.0023
2020-08-14 2020-06-30 13F PACIRA BIOSCIENCES COM 695127100 129,427 -23,752 -15.51 6,791 32.20 0.0015
2020-05-26 2020-03-31 13F/A-1 PACIRA BIOSCIENCES COM 695127100 153,179 -93,863 -37.99 5,137 -54.10 0.0014
2020-05-15 2020-03-31 13F PACIRA BIOSCIENCES COM 695127100 153,179 -93,863 5,137 394.6287
2020-02-14 2019-12-31 13F PACIRA BIOSCIENCES COM 695127100 247,042 76,745 45.07 11,191 72.59 0.0026
2019-11-14 2019-09-30 13F PACIRA BIOSCIENCES COM 695127100 170,297 143,633 538.68 6,484 459.45 0.0017
2019-08-14 2019-06-30 13F PACIRA BIOSCIENCES COM 695127100 26,664 -2,055 -7.16 1,159 6.04 0.0003
2019-05-15 2019-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 28,719 -230,751 -88.93 1,093 -90.21 0.0003
2019-02-14 2018-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 259,470 -16,299 -5.91 11,162 -17.65 0.0033
2019-04-23 2018-09-30 13F/A-2 PACIRA PHARMACEUTICALS COM 695127100 275,769 166,933 153.38 13,554 288.48 0.0034
2018-11-20 2018-09-30 13F/A-1 PACIRA PHARMACEUTICALS COM 695127100 275,769 0 13,554 0.0034
2018-11-14 2018-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 275,769 166,933 13,554
2019-04-23 2018-06-30 13F/A-1 PACIRA PHARMACEUTICALS COM 695127100 108,836 -23,112 -17.52 3,489 -15.11 0.0009
2018-08-14 2018-06-30 13F PACIRA PHARMACEUTICALS COM 695127100 108,836 -23,112 3,489
2019-04-23 2018-03-31 13F/A-1 PACIRA PHARMACEUTICALS COM 695127100 131,948 10,525 8.67 4,110 -25.87 0.0011
2018-05-14 2018-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 131,948 10,525 4,110
2019-04-23 2017-12-31 13F/A-1 PACIRA PHARMACEUTICALS COM 695127100 121,423 27,389 29.13 5,544 57.01 0.0015
2018-02-14 2017-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 121,423 27,389 5,544
2017-11-14 2017-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 94,034 -85,106 -47.51 3,531 -58.68 0.0011
2017-08-11 2017-06-30 13F PACIRA PHARMACEUTICALS COM 695127100 179,140 90,988 103.22 8,545 112.56 0.0026
2017-05-22 2017-03-31 13F/A-1 PACIRA PHARMACEUTICALS COM 695127100 88,152 -32,416 -26.89 4,020 3.24 0.0012
2017-05-12 2017-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 88,152 4,020
2017-02-22 2016-12-31 13F/A-1 PACIRA PHARMACEUTICALS COM 695127100 120,568 10,221 9.26 3,894 3.13 0.0013
2017-02-13 2016-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 120,568 3,894
2016-11-10 2016-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 110,347 -245,919 -69.03 3,776 -68.58 0.0013
2016-08-12 2016-06-30 13F PACIRA PHARMACEUTICALS COM 695127100 356,266 296,240 493.52 12,017 277.89 0.0043
2016-05-12 2016-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 60,026 -60,588 -50.23 3,180 -65.66 0.0012
2016-02-09 2015-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 120,614 26,865 28.66 9,261 140.36 0.0034
2016-02-08 2015-09-30 13F/A-1 PACIRA PHARMACEUTICALS COM 695127100 93,749 29,166 45.16 3,853 -15.63 0.0014
2015-11-09 2015-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 93,749 3,853
2015-08-12 2015-06-30 13F PACIRA PHARMACEUTICALS COM 695127100 64,583 -11,827 -15.48 4,567 -32.73 0.0016
2015-05-14 2015-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 76,410 -77,586 -50.38 6,789 -50.28 0.0025
2015-02-13 2014-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 153,996 55,035 55.61 13,654 42.36 0.0050
2014-12-16 2014-09-30 13F/A-1 PACIRA PHARMACEUTICALS COM 695127100 98,961 -5,910 -5.64 9,591 30.65 0.0037
2014-11-14 2014-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 98,961 9,591
2014-05-13 2014-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 104,871 76,553 270.33 7,341 350.92 0.0031
2014-02-13 2013-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 28,318 -7,851 -21.71 1,628 -6.38 0.0007
2013-11-13 2013-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 36,169 8,084 28.78 1,739 113.64 0.0008
2013-08-08 2013-06-30 13F PACIRA PHARMACEUTICALS COM 695127100 28,085 28,085 814 0.0004
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.